| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |